Phaseline

Targets › IL12A

IL12A (Interleukin-12 subunit alpha): drug programs, companies and trials

3 programs from 3 companies in 16 trials: 7 Phase 2, 5 Phase 1, 3 Phase 4, 1 Phase 3; Oncology, Immunology, Metabolic and endocrine; next expected readout Dec 2026.

Heterodimerizes with IL12B to form the IL-12 cytokine or with EBI3/IL27B to form the IL-35 cytokine. IL-12 is primarily produced by professional antigen-presenting cells (APCs) such as B-cells and dendritic cells (DCs) as well as macrophages and granulocytes and regulates T-cell and natural killer-cell responses, induces the production of interferon-gamma (IFN-gamma), favors the differentiation of T-helper 1 (Th1)…. (UniProt, P29459)

Open in Phaseline: the race on IL12A, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Johnson & Johnson (Janssen)Ustekinumab
Interleukin-12 inhibitor; Interleukin-23 inhibitor
IL12B, IL12A, IL23APhase 3Crohn Disease; Psoriasis; Crohn Disease (CD); Type 1 Diabetes Mellitus …Sep 2027
University Health Network, TorontoICG dye
Interleukin-12 produced by genetically modified AML cells; immune stimulatory cytokine
IL12A, IL12BPhase 2All Solid Tumors; Surgery Site Fistula; Acute Myeloid Leukemia; Melanoma (Skin)Dec 2026
PhilogenIL12-L19L19
Antibody-cytokine fusion protein; IL-12 fused to L19 antibody targeting fibronectin
IL12A, IL12B, FN1Phase 1Advanced Solid TumorDec 2026

Conditions

Crohn Disease (2) Psoriasis (2) Advanced Solid Tumor (1) Crohn Disease (CD) (1) Type 1 Diabetes Mellitus (1) Skin Inflammation (1) Cancer (1) Hematologic and Lymphocytic Disorder (1) Ulcerative Colitis (1) Crohn's Disease (1) All Solid Tumors (1) Surgery Site Fistula (1)

Modalities

protein or peptide (1), antibody (1)

Companies

Philogen (1) Johnson & Johnson (Janssen) (1) University Health Network, Toronto (1)

Related targets

IL12B (3) FN1 (1) IL23A (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.